Clinical Trial Update: BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis [Phase 2]

View source ↗

Summary

This is a Phase 2 long-term treatment trial of BI 655130 for adults with moderate-to-severe ulcerative colitis that has completed. Results were posted in July 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• BI 655130

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Colitis, Ulcerative | Phase 2 | Status: COMPLETED | Results posted: 2024-07-03